Saturday, 17 October 20265:05 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Science

Novartis Discontinues Mid-Stage Lupus Trial In Latest Pipeline Setback

Image: Asianet Newsable. Rights remain with the publisher.

The multi-location study aimed to evaluate the efficacy, safety, and tolerability of iptacopan (LNP023) in addition to standard-of-care treatment in lupus.

Read the full report on Asianet Newsable

Story file

Section
Science
First reported by
Asianet Newsable
Reporter
stocktwits inc
Published
Saturday, 17 October 2026, 4:05 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Science news

See all